Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04270630 · ClinicalTrials.gov registry record · NA
A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04270630 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 14 participants.
The verdict
NCT04270630, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study will be a single-center, prospective, un-blinded, randomized controlled trial evaluating a decision aid tool for older patients considering left heart catheterization (LHC) as treatment for non-ST elevation myocardial infarction (NSTEMI). The study population is 50 total inpatients (25 per study arm) with NSTEMI eligible for elective LHC. The first arm is the control group that will receive standard of care, while the second arm will have access to the decision aid and shared-decision making conversation with one of the co-investigators. Baseline characteristics and surveys/questionnaire data will be collected after study intervention (as applicable), and prior to final decision regarding LHC. Statistical analyses will be conducted on the primary endpoint, decisional conflict score, as well as on various secondary endpoints.
Interventions
- BEHAVIORAL Shared Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2022-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04270630
The ClinicalTrials.gov registry entry for NCT04270630 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Shared Decision Aid is the first listed.
NCT04270630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04270630 about?
NCT04270630 is a clinical study titled "A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI". This study will be a single-center, prospective, un-blinded, randomized controlled trial evaluating a decision aid tool for older patients considering left heart catheterization (LHC) as treatment for non-ST elevation myocardial infarction (NSTEMI). The study population is 50 total inpatients (25 pe...
What is the current status of trial NCT04270630?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-07-01. Estimated completion is 2022-12-01.
What interventions are being tested in trial NCT04270630?
The interventions under investigation include: Shared Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT04270630?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.